Kids Kare

Stannous Fluoride


Den-mat Holdings, Llc.
Human Otc Drug
NDC 59883-404
Kids Kare also known as Stannous Fluoride is a human otc drug labeled by 'Den-mat Holdings, Llc.'. National Drug Code (NDC) number for Kids Kare is 59883-404. This drug is available in dosage form of Gel. The names of the active, medicinal ingredients in Kids Kare drug includes Stannous Fluoride - .969 mg/g . The currest status of Kids Kare drug is Active.

Drug Information:

Drug NDC: 59883-404
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Kids Kare
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Stannous Fluoride
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Den-mat Holdings, Llc.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Gel
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:STANNOUS FLUORIDE - .969 mg/g
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:DENTAL
ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: OTC MONOGRAPH FINAL
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 12 Oct, 2017
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 06 May, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Application Number: part355
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:DEN-MAT HOLDINGS, LLC.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:3FTR44B32Q
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
59883-404-04121.9 g in 1 TUBE (59883-404-04)12 Oct, 2017N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Purpose anticavity

Product Elements:

Kids kare stannous fluoride glycerin trolamine berry anhydrous citric acid stannous fluoride fluoride ion ascorbic acid carbomer 934

Indications and Usage:

Uses aids in the prevention of dental cavities.

Warnings:

Warnings this is an anticavity fluoride preventive treatment gel, not a toothpaste. read directions carefully before using.

When Using:

When using this product it may produce surface staining of the teeth, adequate tooth brushing may prevent these stains which are not harmful or permanent and may be removed by your dentist.

Dosage and Administration:

Directions adults and children 6 years of age and older: use once a day after brushing your teeth with a toothpaste. apply the get to your teeth and brush thoroghly. allow the gel to remain on your teeth for 1 minute and then spit out. do not swallow the gel. do not eat or drink for 30 minutes after brushing. instruct children under 12 years of age in the use of this product (to minimize swallowing). supervise children as necessary until capable of using without supervision. children under 6 years of age: consult a dentist or doctor.

Package Label Principal Display Panel:

Principal display panel kids kare™ preventative treatment 0.4% stannous fluoride brush-on gel berry flavor important: read directions carefully net wt. 4.3 oz. (121.9 g) kids kare stannous gel

Further Questions:

Questions or comments? 1-800-752-2564


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.